Stock screener
All disclosures →
EDGAR →
LGND
Conviction 99HealthcareScan · Thu, Jun 25, 2026LGND$295.87+3.85%
ResistanceSupportVol 14Insider sellCongress buyCongress sell7
12
Vol MA14 505.62K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price295.87
Change+3.85%
Gap+0.56%
Rel volume1.95×
Avg volume405.75K
Avg $ vol107.98M
SMA 20252.24
SMA 50236.06
SMA 200203.68
Price vs 50+25.34%
Price vs 200+45.26%
MA stackbullish
50/200 cross—
Supertrendup · 256.21
RSI (14)78
MACD hist4.12
MACD cross—
Stoch %K / %D93 / 94
ADX (14)28
+DI / −DI37 / 17
RSI divergence—
MACD divergence—
ATR %+3.89%
ADR %3.86%
52w high295.87
52w low112.56
From 52w high+0.00%
Above 52w low+162.86%
New 52w highYes
SqueezeOff
Bollinger width30.08%
%B1.08
Donchian pos94.38%
Donchian high300.23
Donchian low222.76
AVWAP (52w high)294.20
vs AVWAP high+0.57%
AVWAP (52w low)197.40
vs AVWAP low+49.88%
OBV trendUp
Chaikin MF (20)0.37
Today vs 20d1.95×
Avg vol (14d)505.62K
Avg vol (20d)405.75K
Avg $ vol (20d)107.98M
Market cap5.93B
RS 3m (vs SPY)+29.03%
RS 6m (vs SPY)+34.48%
RS line new highYes
Trend template8/8
Technical rank93.5
1 week+12.44%
1 month+25.73%
3 months+44.64%
6 months+49.46%
1 year+150.27%
YTD+55.63%
P/E47.64
P/B5.95
P/S22.12
P/FCF121.24
EPS6.13
Div yield—
ROE12.48%
ROA8.12%
Debt/Eq0.03
Current21.28
EV/EBITDA78.13
Gross margin—
Net margin46.42%
Rev growth60.40%
EPS growth3186.63%
Price target280.67
Target upside-5.14%
Analyst ratingBuy
Institutional114.71%
Ent. value5.84B
Revenue51.72M
Net income-13.35M
Gross profit—
Free cash flow48.91M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out20.04M
Employees47
ListedFri, Nov 25, 1994
Free float18.87M
Float %95.9%
Short interest1.64M
Days to cover8.2d
Short volume86.1%
Squeeze score77 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast$1.26 · 3 est
Last EPS vs est−$0.67 vs $0.98
Last surprise-168.4% miss
Setup gradeA+
Conviction99 / 100
Pattern quality—
Tech rank93.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance250.07
Support202.60
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in LGND · 2 recent
Insider activity
SEC Form 4 transactions in LGND · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Sabba Stephen L Director · Common Stock · 2026-06-16 | Exercise | 2.15K | $142K | 2026-06-16 | 2026-06-18 |
Sabba Stephen L Director · Non-Qualified Stock Option (right to buy) · 2026-06-16 | Exercise | 2.15K | — | 2026-06-16 | 2026-06-18 |
Sabba Stephen L Director · Common Stock · 2026-06-16 | Sell | 2.15K | $545K | 2026-06-16 | 2026-06-18 |
Aryeh Jason Director · Common Stock · 2026-06-11 | Sell | 4.5K | $1.1M | 2026-06-11 | 2026-06-12 |
Aryeh Jason Director · Common Stock · 2026-06-10 | Sell | 500 | $125K | 2026-06-10 | 2026-06-12 |
Aryeh Jason Director · Non-Qualified Stock Option (right to buy) · 2026-06-05 | Grant | 2.94K | — | 2026-06-05 | 2026-06-12 |
Aryeh Jason Director · Common Stock · 2026-06-05 | Grant | 836 | — | 2026-06-05 | 2026-06-12 |
LAMATTINA JOHN L Director · Non-Qualified Stock Option (right to buy) · 2026-06-05 | Grant | 2.94K | $0 | 2026-06-05 | 2026-06-09 |
KOZARICH JOHN W Director · Common Stock · 2026-06-05 | Grant | 836 | $0 | 2026-06-05 | 2026-06-09 |
LAMATTINA JOHN L Director · Common Stock · 2026-06-05 | Grant | 836 | $0 | 2026-06-05 | 2026-06-09 |
SEC filings
EDGAR filings in LGND · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.